Investing.com - Rezolute reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Rezolute announced earnings per share of $-0.37 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.38 on revenue of $0.00.
Rezolute 's are down 43% and is trading at $2.70 , still down 73.24% from its 52 week high of $10.09 set on Wednesday, September 15, 2021.
Rezolute follows other major Healthcare sector earnings this month
Rezolute's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.5392 on revenue of $5.69B, for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar